Medications for Thromboembolism
4 results
Dabigatran etexilate (dabigatran etexilate)
(Dabigatran Etexilate)Mylan Pharmaceuticals Inc.
Usage: Dabigatran etexilate capsules are indicated for reducing the risk of stroke and systemic embolism in non-valvular atrial fibrillation, treating and preventing deep vein thrombosis and pulmonary embolism in adults and pediatric patients aged 8-17, and preventing recurrence of venous thromboembolic events.
Dabigatran etexilate (dabigatran etexilate)
(Dabigatran etexilate)Dr. Reddy's Laboratories Inc.
Usage: Dabigatran etexilate capsules are indicated for reducing stroke risk in non-valvular atrial fibrillation, treating deep venous thrombosis and pulmonary embolism, providing prophylaxis following hip replacement surgery, and treating and preventing venous thromboembolic events in pediatric patients aged 8 to under 18 years.
Dipyridamole (dipyridamole)
(DIPYRIDAMOLE)Amneal Pharmaceuticals of New York LLC
Usage: Dipyridamole tablets are indicated as an adjunct to coumarin anticoagulants for preventing postoperative thromboembolic complications following cardiac valve replacement.
Pradaxa (dabigatran etexilate mesylate)
(dabigatran etexilate mesylate)Boehringer Ingelheim Pharmaceuticals Inc.
Usage: PRADAXA Capsules are indicated for reducing the risk of stroke and systemic embolism in non-valvular atrial fibrillation, treating deep venous thrombosis and pulmonary embolism in adults, preventing recurrence of these conditions, and for prophylaxis after hip replacement surgery. It also treats and prevents venous thromboembolic events in pediatric patients.